NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
In this study the serum concentration of testosterone and its main metabolite DHT will be
measured in hypogonadal men using intranasal testosterone (Nasobol). Different treatment
regimens (once and twice daily) and administration times will be tested. The serum levels
obtained will be compared with those of healthy men.
It is expected that intranasal administration of Nasobol will restore testosterone and DHT
levels to nearly normal.